- Entry
- $3.07
- Final
- $1.48 -51.8%
- Target
- $10.20
- Score
- -0.22
Hey, I don't know why more people aren't talking about this, so here I go doing my best to articulate how excited I am for this stock. # What the hell is it? Autolus Therapeutics is a biopharmaceutical company specializing in CAR-T cell therapies aimed at treating various cancers. Their flagship product, Aucatzyl (obecabtagene autoleucel), targets relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). # Recent Developments * **FDA Approval:** On November 8, 2024, the FDA approved Aucatzyl …
— ORIGINAL POST ·
$AUTL - Insanely Undervalued Cancer Treatment
· r/wallstreetbets
· Feb 5, 2025